Table 1.
Baseline clinical characteristics of 71 postmenopausal women (mean ± SD).
| Variables | RT + ISO | RT + P | No RT + ISO | No RT + P | P value* |
|---|---|---|---|---|---|
| (n = 15) | (n = 18) | (n = 20) | (n = 18) | ||
| Age (years) | 55.7 ± 7.0 | 56.6 ± 8.8 | 56.0 ± 5.8 | 55.3 ± 8.0 | .99 |
| Postmenopause (years) | 7.7 ± 5.3 | 8.7 ± 6.1 | 6.5 ± 4.9 | 7.7 ± 6.2 | .64 |
| FSH (mUI/mL) | 74.0 ± 27.7 | 71.8 ± 24.3 | 63.0 ± 21.1 | 63.3 ± 21.3 | .15 |
| E2 (pg/mL) | 23.1 ± 4.8 | 21.7 ± 4.3 | 22.5 ± 4.8 | 23.3 ± 5.8 | .59 |
| Weight (kg) | 73.2 ± 15.1 | 62.8 ± 9.8(a) | 75.0 ± 12.9(a) | 73.7 ± 12.6 | .03 |
| Height (cm) | 154.9 ± 7.0 | 154.7 ± 5.6 | 158.1 ± 5.8 | 155.6 ± 5.2 | .27 |
| WC (cm) | 95.7 ± 10.1 | 87.3 ± 7.7 | 94.1 ± 12.3 | 95.1 ± 11.9 | .09 |
| BMI (kg/m2) | 30.3 ± 4.7 | 26.0 ± 3.0(a) | 30.1 ± 4.7 | 30.4 ± 5.3(a) | .03 |
| MM (kg) | 34.0 ± 6.2 | 30.3 ± 4.1 | 34.0 ± 4.2 | 33.6 ± 4.0 | .08 |
| MM-Limbs (kg) | 13.6 ± 2.8 | 12.0 ± 1.9 | 13.7 ± 2.0 | 13.6 ± 2.0 | .08 |
| MM (%) | 52.2 ± 4.5 | 54.3 ± 4.2 | 51.2 ± 6.2 | 51.0 ± 5.1 | .20 |
| Trunk fat mass (kg) | 14.3 ± 4.4 | 12.3 ± 3.2 | 15.8 ± 5.4 | 14.8 ± 4.4 | .11 |
| Body fat (%) | 46.2 ± 4.9 | 43.0 ± 4.4 | 46.8 ± 6.7 | 46.5 ± 5.7 | .12 |
| Strength muscle (kg) | 30.7 ± 9.2 | 31.3 ± 6.8 | 33.0 ± 10.2 | 32.7 ± 7.9 | .15 |
FSH: follicle-stimulating hormone; E2: estradiol; WC: waist circumference; BMI: body mass index; MM: muscle mass; SD: standard deviations; ISO: isoflavone; PL: placebo; RT: resistance training.
*Significant difference among groups (P < .05) (one-way ANOVA),(a)With significantly difference between groups (P < .05).